All Stories

  1. Antimicrobial Stewardship in Korea: A Strategic Roadmap for Future Sustainability
  2. Nationwide Survey of Antimicrobial Stewardship in Korean Hospitals: Insights From the Early Stage of the 2024 National Pilot Implementation
  3. Dual Surveillance of Surgical Site Infections Using CDC and ASEPSIS Criteria: Clinical and Economic Outcomes in Colorectal and Small Bowel Surgery
  4. High-throughput microfluidic spheroid technology for early detection of colistin-induced nephrotoxicity with gradient-based analysis
  5. Trends of antibiotic use at the end-of-life of cancer and non-cancer decedents: a nationwide population-based longitudinal study (2006–2018) – CORRIGENDUM
  6. The Microbiological Characteristics of Acinetobacter Baumannii Associated With Early Mortality in Patients With Bloodstream Infection
  7. Quantitative and qualitative evaluation of antimicrobial usage: the first step for antimicrobial stewardship
  8. Benchmarking Antimicrobial Drug Use: Opportunities and Challenges
  9. Trends of antibiotic use at the end-of-life of cancer and non-cancer decedents: a nationwide population-based longitudinal study (2006–2018)
  10. Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea
  11. Case Report and Literature Review of Occupational Transmission of Monkeypox Virus to Healthcare Workers, South Korea
  12. Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
  13. In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection
  14. Development of diagnostic tests for pathogen identification and detection of antimicrobial resistance on WHO global priority pathogens using modular real-time nucleic acid amplification test
  15. Anti-Alpha-Toxin Antibody Responses and Clinical Outcomes of Staphylococcus aureus Bacteremia
  16. Current Status of Outpatient Parenteral Antimicrobial Therapy in Korea: Experience of a Single University-Affiliated Acute-Care Hospital
  17. Developing Core Elements and Checklist Items for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals: A Modified Delphi Survey
  18. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results
  19. Possibility of Decreasing Incidence of Human Immunodeficiency Virus Infection in Korea
  20. Corrigendum: Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
  21. Clinical and economic burden of bacteremia due to multidrug-resistant organisms in Korea: a prospective case control study
  22. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia
  23. Temporal Transcriptome Analysis of SARS-CoV-2-Infected Lung and Spleen in Human ACE2-Transgenic Mice
  24. Effects of implementing a clinical pathway on antibiotic prophylaxis for patients who underwent an elective surgery
  25. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
  26. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models
  27. Interspecies differences in clinical characteristics and risk factors for third-generation cephalosporin resistance between Escherichia coli and Klebsiella pneumoniae bloodstream infection in patients with liver cirrhosis
  28. Clinical and molecular epidemiology of invasive group B Streptococcus infections in adults in a referral center in Korea
  29. Clinical impact of clonal hematopoiesis on severe COVID- 19 patients without canonical risk factors
  30. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
  31. Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
  32. Positivity rates of mycobacterial culture in patients with tuberculous spondylitis according to methods and sites of biopsies: An analysis of 206 cases
  33. Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weight analysis in two large, prospectively evaluated cohorts
  34. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries
  35. Different levels of humoral and cellular immunity to varicella-zoster virus in seropositive healthcare workers
  36. The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses
  37. Stepwise Expansion of Antimicrobial Stewardship Programs and Its Impact on Antibiotic Use and Resistance Rates at a Tertiary Care Hospital in Korea
  38. Laboratory information management system for COVID-19 non-clinical efficacy trial data
  39. Appropriateness of antibiotic prescriptions during hospitalization and ambulatory care: a multicentre prevalence survey in Korea
  40. Different clinical characteristics and impact of carbapenem-resistance on outcomes between Acinetobacter baumannii and Pseudomonas aeruginosa bacteraemia: a prospective observational study
  41. Prevalence of and factors associated with inappropriate Clostridioides difficile testing in a teaching hospital in Korea
  42. Lung ultrasound for early diagnosis and severity assessment of pneumonia in patients with coronavirus disease 2019
  43. Evaluation of Patients’ Adverse Events During Contact Isolation for Vancomycin-Resistant Enterococci Using a Matched Cohort Study With Propensity Score
  44. Prescriptions patterns and appropriateness of usage of antibiotics in non-teaching community hospitals in South Korea: a multicentre retrospective study
  45. Comparative Genomic Analysis of the Human Variant of Methicillin-Resistant Staphylococcus aureus CC398 in Japan and Korea
  46. Changes in Anxiety Level and Personal Protective Equipment Use Among Healthcare Workers Exposed to COVID-19
  47. Comprehensive Rehabilitation in Severely Ill Inpatients With COVID-19: A Cohort Study in a Tertiary Hospital
  48. Core Elements for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals
  49. Current Status and Prospect of Qualitative Assessment of Antibiotics Prescriptions
  50. Development of a Roadmap for the Antimicrobial Usage Monitoring System for Medical Institutions in Korea: a Delphi Study
  51. Development of the Korean Standardized Antimicrobial Administration Ratio as a Tool for Benchmarking Antimicrobial Use in Each Hospital
  52. Diagnostic Performance, Stability, and Usability of Self-Collected Combo Swabs and Saliva for Coronavirus Disease 2019 Diagnosis: A Case-Control Study
  53. Implementation of Procalcitonin in Antibiotic Stewardship: Derivation of a Consensus Algorithm for Procalcitonin Use in Clinical Practice
  54. Performance of STANDARD™ M10 SARS-CoV-2 Assay for the Diagnosis of COVID-19 from a Nasopharyngeal Swab
  55. Usefulness of ELISA Using Total Antibody against Plant-Expressed Recombinant Nucleocapsid Protein of SARS-CoV-2
  56. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial
  57. Are coveralls required as personal protective equipment during the management of COVID-19 patients?
  58. Utility and Applicability of Rapid Diagnostic Testing in Antimicrobial Stewardship in the Asia-Pacific Region: A Delphi Consensus
  59. Clonal hematopoiesis is associated with risk of severe Covid-19
  60. Clinical and immunological signatures of severe COVID-19 in previously healthy patients with clonal hematopoiesis
  61. Impact of COVID-19 and Associated Preventive Measures on Cardiometabolic Risk Factors in South Korea
  62. Status of antimicrobial stewardship programmes in Korean hospitals including small to medium-sized hospitals and the awareness and demands of physicians: a nationwide survey in 2020
  63. Potential Impact of the Involvement of Clinical Pharmacists in Antimicrobial Stewardship Programs on the Incidence of Antimicrobial-Related Adverse Events in Hospitalized Patients: A Multicenter Retrospective Study
  64. Genetic regulation ofOAS1nonsense-mediated decay underlies association with risk of severe COVID-19
  65. Mapping the human genetic architecture of COVID-19
  66. It Is Time to Address the Isolation Policy for Patients Colonized with Vancomycin-resistant Enterococci
  67. Rapid diagnostic testing for antimicrobial stewardship: Utility in Asia Pacific
  68. Impact of a computerised clinical decision support system on vancomycin loading and the risk of nephrotoxicity
  69. Impact of Immunosuppressive Agents on Clinical Manifestations and Outcome of Staphylococcus aureus Bloodstream Infection: A Propensity Score–Matched Analysis in 2 Large, Prospectively Evaluated Cohorts
  70. A call for antimicrobial stewardship in patients with COVID-19: a nationwide cohort study in Korea
  71. A standardized glucose–insulin–potassium infusion protocol in surgical patients: Use of real clinical data from a clinical data warehouse
  72. Development of key quality indicators for appropriate antibiotic use in the Republic of Korea: results of a modified Delphi survey
  73. Whole-Genome Sequencing for Investigating a Health Care-Associated Outbreak of Carbapenem-Resistant Acinetobacter baumannii
  74. Stereotypic neutralizing V H antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals
  75. Are the Current Guidelines Sufficient to Establish Infection Control Strategies for COVID-19 Related Issues in Hospitals?
  76. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19
  77. Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19
  78. PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19
  79. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
  80. Early rehabilitation in a critically ill inpatient with COVID-19
  81. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study
  82. Pandemic preparedness of an academic medical centre in the Republic of Korea
  83. Toll-like receptor 2 downregulation and cytokine dysregulation predict mortality in patients with Staphylococcus aureus bacteremia
  84. Clonal hematopoiesis is associated with risk of severe Covid-19
  85. Dysfunctional accessory gene regulator (agr) as a prognostic factor in invasive Staphylococcus aureus infection: a systematic review and meta-analysis
  86. Pneumocystis jirovecii pneumonia in diffuse large B‐cell Lymphoma treated with R‐CHOP
  87. Human resources required for antimicrobial stewardship activities for hospitalized patients in Korea
  88. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
  89. Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
  90. Impact of national policy on hand hygiene promotion activities in hospitals in Korea
  91. Predictive scoring models for persistent gram-negative bacteremia that reduce the need for follow-up blood cultures: a retrospective observational cohort study
  92. Face masks and containment of COVID-19: experience from South Korea
  93. Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility
  94. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity
  95. Lung ultrasound for early diagnosis and severity assessment of pneumonia in patients with coronavirus disease 2019
  96. Stereotypic Neutralizing VHClonotypes Against SARS-CoV-2 RBD in COVID-19 Patients and the Healthy Population
  97. Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors
  98. Management of Acute Stroke Patients Amid the Coronavirus Disease 2019 Pandemic: Scientific Statement of the Korean Stroke Society
  99. Impact of Public Health Interventions on Seasonal Influenza Activity During the COVID-19 Outbreak in Korea
  100. Microbial Etiology of Pyogenic Vertebral Osteomyelitis According to Patient Characteristics
  101. Pilot Study of Aerosolised Plus Intravenous Vancomycin in Mechanically Ventilated Patients with Methicillin-Resistant Staphylococcus Aureus Pneumonia
  102. Current status of antimicrobial stewardship programmes in Korean hospitals: results of a 2018 nationwide survey
  103. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19
  104. Clinical Score System to Differentiate Severe Fever with Thrombocytopenia Syndrome Patients from Patients with Scrub Typhus or Hemorrhagic Fever with Renal Syndrome in Korea
  105. Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service
  106. Development of Antibiotic Classification for Measuring Antibiotic Usage in Korean Hospitals Using a Modified Delphi Method
  107. IFN-γ is Produced by Pd-1 <sup>+</sup> Cells Among SARS-CoV-2-Specific MHC-I Multimer+CD8 <sup>+</sup> T Cells in Acute and Convalescent COVID-19 Patients
  108. Korean Registry for Improving Sepsis Survival (KISS): Protocol for a Multicenter Cohort of Adult Patients with Sepsis or Septic Shock
  109. Psychological Consequences of Survivors of COVID-19 Pneumonia 1 Month after Discharge
  110. Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients
  111. A Prospective Cohort Study of Durations of Staphylococcus aureus Bacteremia According to Different Phenotypes and a New Concept of Persistent Bacteremia
  112. Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors
  113. Chlorhexidine sensitivity in staphylococci isolated from patients with central line-associated bloodstream infection
  114. Redundant combinations of antianaerobic antimicrobials: impact of pharmacist-based prospective audit and feedback and prescription characteristics
  115. Impact of antimicrobial treatment duration on outcome of Staphylococcus aureus bacteraemia: a cohort study
  116. Prevalence of cryptococcal antigenemia in hospitalized patients with liver cirrhosis
  117. Comparison of pyogenic postoperative and native vertebral osteomyelitis
  118. The effect of incorporating covert observation into established overt observation-based hand hygiene promotion programs
  119. Prospective evaluation of a rapid antimicrobial susceptibility test (QMAC-dRAST) for selecting optimal targeted antibiotics in positive blood culture
  120. Efficacy of Intranasal Administration of the Recombinant Endolysin SAL200 in a Lethal Murine Staphylococcus aureus Pneumonia Model
  121. Clinical and Molecular Characterization of Panton–Valentine Leukocidin-Positive InvasiveStaphylococcus aureusInfections in Korea
  122. Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
  123. The microbiological characteristics of Staphylococcus aureus isolated from patients with native valve infective endocarditis
  124. Clinical Prediction Score for Community-Onset Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Species
  125. Delays in Isolating Patients Admitted to Hospital with Pulmonary Tuberculosis in Korea
  126. Immunogenicity and Safety of Influenza Vaccination in Cancer Patients Receiving Immune Checkpoint Inhibitor
  127. Immunogenicity of the Varicella-Zoster Vaccine in Community-Dwelling Non-robust Elderly Individuals Compared to Robust Elderly Individuals: A Prospective Cohort Study
  128. Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care
  129. Healthcare-associated infections in intensive care units in Taiwan, South Korea, and Japan: recent trends based on national surveillance reports
  130. Trends in device utilization ratios in intensive care units over 10-year period in South Korea: device utilization ratio as a new aspect of surveillance
  131. Microarray-Based Nucleic Acid Assay and MALDI-TOF MS Analysis for the Detection of Gram-Negative Bacteria in Direct Blood Cultures
  132. Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics
  133. Delayed diagnosis of extrapulmonary tuberculosis presenting as fever of unknown origin in an intermediate-burden country
  134. Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea
  135. Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection
  136. Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection
  137. Risk factors for poor outcome in community-onset Clostridium difficile infection
  138. A Risk-Scoring System for Predicting Methicillin Resistance in Community-OnsetStaphylococcus aureusBacteremia in Korea
  139. Emergence of Daptomycin-Nonsusceptible Methicillin-ResistantStaphylococcus aureusClinical Isolates Among Daptomycin-Naive Patients in Korea
  140. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease
  141. The Genetic Polymorphism UGT1A4*3 Is Associated with Low Posaconazole Plasma Concentrations in Hematological Malignancy Patients Receiving the Oral Suspension
  142. Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence
  143. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU)
  144. Direct rapid antibiotic susceptibility test (dRAST) for blood culture and its potential usefulness in clinical practice
  145. Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea
  146. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea
  147. Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies
  148. Duration and Persistence of Staphylococcus Aureus Bacteremia: A Prospective Cohort Study
  149. Hand hygiene
  150. Optimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine
  151. Two-Year Hospital-Wide Surveillance of Central Line-Associated Bloodstream Infections in a Korean Hospital
  152. Risk factors for suboptimal drug concentration of posaconazole oral suspension in patients with hematologic malignancy
  153. Occupational blood exposures in health care workers: incidence, characteristics, and transmission of bloodborne pathogens in South Korea
  154. The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship—results from an international cross-sectional survey
  155. Validation of the Korean National Healthcare-associated Infections Surveillance System (KONIS): an intensive care unit module report
  156. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
  157. agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia
  158. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis
  159. Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea
  160. Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies
  161. Impact of Intervention by an Antimicrobial Stewardship Team on Conversion from Intravenous to Oral Fluoroquinolones
  162. Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections
  163. Impact of a hand hygiene campaign in a tertiary hospital in South Korea on the rate of hospital-onset methicillin-resistant Staphylococcus aureus bacteremia and economic evaluation of the campaign
  164. Limited usefulness of the interferon-gamma release assay in patients with HIV infections and negative tuberculin skin test results in a country with an intermediate tuberculosis burden
  165. Association between Type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus
  166. Comparison of clinical characteristics and outcomes of spontaneous bacterial peritonitis and culture negative neutrocytic ascites
  167. Comparison of characteristics of culture-negative pyogenic spondylitis and tuberculous spondylitis: a retrospective study
  168. Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort
  169. Small-Colony Variants in Persistent and RecurrentStaphylococcus aureusBacteremia
  170. Viral Load Kinetics of MERS Coronavirus Infection
  171. Cancer-specific incidence rates of tuberculosis
  172. Influences of faculty evaluating system on educational performance of medical school faculty
  173. Electronic Alerts with Automated Consultations Promote Appropriate Antimicrobial Prescriptions
  174. Hemophagocytic lymphohistiocytosis associated with SFTS virus infection
  175. Five-year decreased incidence of surgical site infections following gastrectomy and prosthetic joint replacement surgery through active surveillance by the Korean Nosocomial Infection Surveillance System
  176. Immune reconstitution inflammatory syndrome versus non-immune reconstitution inflammatory syndrome lymphoma in HIV patients on antiretroviral therapy
  177. Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
  178. Extensive Viable Middle East Respiratory Syndrome (MERS) Coronavirus Contamination in Air and Surrounding Environment in MERS Isolation Wards
  179. Impact of the multiplex polymerase chain reaction in culture-positive samples on appropriate antibiotic use in patients with staphylococcal bacteremia
  180. Trends in the distribution and antimicrobial susceptibility of causative pathogens of device-associated infection in Korean intensive care units from 2006 to 2013: results from the Korean Nosocomial Infections Surveillance System (KONIS)
  181. Vertebral osteomyelitis caused by non-tuberculous mycobacteria: Predisposing conditions and clinical characteristics of six cases and a review of 63 cases in the literature
  182. The purpose and appropriateness of carbapenem use in a single university hospital, 2009–2013
  183. Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease
  184. Isolation of Middle East Respiratory Syndrome Coronavirus from a Patient of the 2015 Korean Outbreak
  185. Antibiotic Control Policies in South Korea, 2000-2013
  186. Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection
  187. Collaborative Intervention of Middle East Respiratory Syndrome: Rapid Response Team
  188. Serotype Distribution and Antimicrobial Susceptibilities of InvasiveStreptococcus pneumoniaeIsolates from Adults in Korea from 1997 to 2012
  189. Usefulness of Multiplex Real-Time PCR for Simultaneous Pathogen Detection and Resistance Profiling of Staphylococcal Bacteremia
  190. Clinical and Molecular Characterization of Invasive Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Infections in Korean Hospitals
  191. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea
  192. Impact of area under the concentration–time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia
  193. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection
  194. Which tissues are best for microbiological diagnosis in patients with pyogenic vertebral osteomyelitis undergoing needle biopsy?
  195. Trends in the incidence rate of device-associated infections in intensive care units after the establishment of the Korean Nosocomial Infections Surveillance System
  196. Why is asymptomatic bacteriuria overtreated?: A tertiary care institutional survey of resident physicians
  197. Corrigendum to “Outbreak among healthy newborns due to a new variant of USA300-related meticillin-resistant Staphylococcus aureus” [J Hosp Infect 87 (2014) 145–151]
  198. Disseminated Aspergillosis in the Immunocompetent Host: A Case Report and Literature Review
  199. Clinical Characteristics and Risk Factors of Pyogenic Spondylitis Caused by Gram-Negative Bacteria
  200. Discrepancy in perceptions regarding patient participation in hand hygiene between patients and health care workers
  201. National hand hygiene campaign in Korea: A pilot study
  202. National hand hygiene campaign in Korea-progress and challenges
  203. agrDysfunction Affects Staphylococcal Cassette ChromosomemecType-Dependent Clinical Outcomes in Methicillin-Resistant Staphylococcus aureus Bacteremia
  204. Erratum for Kim et al., Inappropriate Continued Empirical Vancomycin Use in a Hospital with a High Prevalence of Methicillin-Resistant Staphylococcus aureus
  205. Factors Influencing Culture Positivity in Pyogenic Vertebral Osteomyelitis Patients with Prior Antibiotic Exposure
  206. Multidrug-Resistant Gram-Positive Bacterial Infections
  207. Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities
  208. Impact of an Antimicrobial Stewardship Program on Unnecessary Double Anaerobic Coverage Prescription
  209. Antiviral Treatment Guidelines for Middle East Respiratory Syndrome
  210. Clinical and Epidemiological Factors Associated with Methicillin Resistance in Community-Onset Invasive Staphylococcus aureus Infections: Prospective Multicenter Cross-Sectional Study in Korea
  211. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance
  212. Inappropriate Continued Empirical Vancomycin Use in a Hospital with a High Prevalence of Methicillin-Resistant Staphylococcus aureus
  213. Google unveils a glimpse of allergic rhinitis in the real world
  214. The burden of nosocomial staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study
  215. Outbreak among healthy newborns due to a new variant of USA300-related meticillin-resistant Staphylococcus aureus
  216. Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection
  217. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study
  218. Diagnostic value of direct fluorescence antibody staining for detecting Pneumocystis jirovecii in expectorated sputum from patients with HIV infection
  219. Antibiotic susceptibility and molecular epidemiology of Panton–Valentine leukocidin-positive meticillin-resistant Staphylococcus aureus: An international survey
  220. Area under the concentration–time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia
  221. High prevalence of low bone mass and associated factors in Korean HIV-positive male patients undergoing antiretroviral therapy
  222. Behavioral Perspectives toward Hand Hygiene Promotion
  223. A Survey of Antimicrobial Stewardship Programs in Korean Hospitals
  224. Appropriateness of Surgical Antibiotic Prophylaxis in a Tertiary Hospital
  225. Korean Nosocomial Infections Surveillance System, Intensive Care Unit Module Report: Summary of Data from July 2011 through June 2012
  226. Low Compliance with National Guidelines for Preventing Transmission of Group 1 Nationally Notifiable Infectious Diseases in Korea
  227. Oral Antimicrobial Therapy: Efficacy and Safety for Methicillin-ResistantStaphylococcus aureusInfections and Its Impact on the Length of Hospital Stay
  228. Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study
  229. Association of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea
  230. Risk factors of surgical site infections after supratentorial elective surgery: A focus on the efficacy of the wound-drain-tip culture
  231. Can a routine follow-up blood culture be justified in Klebsiella pneumoniaebacteremia? a retrospective case–control study
  232. Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae
  233. Comprehensive Approach to Prevention of Central Line-Associated Bloodstream Infection
  234. Differentiating rapid- and slow-growing mycobacteria by difference in time to growth detection in liquid media
  235. Incidence and Risk Factors of Tuberculosis in Patients with Human Immunodeficiency Virus Infection
  236. Prevalence of Plasmid-Mediated Quinolone Resistance Genes and Ciprofloxacin Resistance in Pediatric Bloodstream Isolates of Enterobacteriaceae over a 9-Year Period
  237. Difference in agr Dysfunction and Reduced Vancomycin Susceptibility between MRSA Bacteremia Involving SCCmec Types IV/IVa and I–III
  238. Differences in the Risk Factors for Surgical Site Infection between Total Hip Arthroplasty and Total Knee Arthroplasty in the Korean Nosocomial Infections Surveillance System (KONIS)
  239. Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: Susceptibility and clinical outcome
  240. Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea
  241. Real-time PCR surveillance of vanA for vancomycin-resistant Enterococcus faecium
  242. Prospective Nationwide Surveillance of Surgical Site Infections after Gastric Surgery and Risk Factor Analysis in the Korean Nosocomial Infections Surveillance System (KONIS)
  243. Empirical Use of Ciprofloxacin for Acute Uncomplicated Pyelonephritis Caused by Escherichia coli in Communities Where the Prevalence of Fluoroquinolone Resistance Is High
  244. Microbiologically and Clinically Diagnosed Vertebral Osteomyelitis: Impact of Prior Antibiotic Exposure
  245. A Case of Imported Plasmodium malariae Malaria
  246. Nosocomial Meningitis: Moving beyond Description to Prevention
  247. First Korean Case of Robinsoniella peoriensis Bacteremia in a Patient with Aspiration Pneumonia
  248. Changes in Antimicrobial Susceptibility of Blood Isolates in a University Hospital in South Korea, 1998-2010
  249. Effect of Ritonavir-boosting on Atazanavir Discontinuation due to Jaundice in HIV-infected Koreans
  250. Multiple Opportunistic Infections and Primary Central Nervous System Lymphoma in a Patient with Idiopathic CD4+ T-lymphocytopenia
  251. Opinions of Infectious Disease Specialists on the Current Method for Isolation of Group 1 Nationally Notifiable Infectious Diseases in Korea
  252. Risk Factors for Febrile Neutropenia during Chemotherapy for HIV-Related Lymphoma
  253. Outcome of cefazolin prophylaxis for total knee arthroplasty at an institution with high prevalence of methicillin-resistant Staphylococcus aureus infection
  254. Risk factors for 30-day mortality in adult patients with pneumococcal bacteraemia, and the impact of antimicrobial resistance on clinical outcomes
  255. Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia?
  256. Molecular characterization of methicillin-resistant Staphylococcus aureus obtained from the anterior nares of healthy Korean children attending daycare centers
  257. Late presentation of HIV disease and its associated factors among newly diagnosed patients before and after abolition of a government policy of mass mandatory screening
  258. Evaluation of three phenotypic identification systems for clinical isolates of Raoultella ornithinolytica
  259. Molecular Characterization of Methicillin-Resistant Staphylococcus aureus Isolates in Korea
  260. Genotype of Varicella-Zoster Virus Isolates in South Korea
  261. Effect of Routine Sterile Gloving on Contamination Rates in Blood Culture
  262. Clinical Features and Rate of Infective Endocarditis in Non-Faecalis and Non-faecium Enterococcal Bacteremia
  263. Regional Difference of Antibiotic Resistance ofHelicobacter pyloriStrains in Korea
  264. The Development of a Korean Drug Dosing Database
  265. A Prediction Rule to Identify Severe Cases among Adult Patients Hospitalized with Pandemic Influenza A (H1N1) 2009
  266. Cold Shock InducesqnrAExpression inShewanella algae
  267. A Comparative Study of Pyogenic and Tuberculous Spondylodiscitis
  268. Change in Antibiotic Resistance of Helicobacter pylori Strains and the Effect of A2143G Point Mutation of 23S rRNA on the Eradication of H. pylori in a Single Center of Korea
  269. A rapid genotyping test for the simultaneous detection and subtyping of group B streptococci: the frequency of molecular subtypes of group B streptococci in Korea
  270. A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers
  271. Genetic Factors Influencing Severe Atazanavir‐Associated Hyperbilirubinemia in a Population with Low UDP‐Glucuronosyltransferase 1A1*28 Allele Frequency
  272. A Case of Cerebral Toxoplasmosis Following Tandem Autologous Stem Cell Transplantation in a Multiple Myeloma Patient
  273. A Case of Group G Streptococcal Toxic Shock Syndrome
  274. Clinical Features, Risk Factors and Outcomes of Bacteremia due to Enterococci with High-Level Gentamicin Resistance: Comparison with Bacteremia due to Enterococci without High-Level Gentamicin Resistance
  275. Detection of Enterovirus using Real-Time Nucleic Acid Sequence-based Amplification
  276. Incidence of Atazanavir-associated Hyperbilirubinemia in Korean HIV Patients: 30 Months Follow-up Results in a Population with Low UDP-glucuronosyltransferase1A1*28 Allele Frequency
  277. Spectrum of Intracranial Parenchymal Lesions in Patients with Human Immunodeficiency Virus Infection in the Republic of Korea
  278. Transferable Quinolone Resistance in Vibrio cholerae
  279. Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome
  280. Usefulness of routine lumbar puncture in non-HIV patients with latent syphilis of unknown duration
  281. Salvage Treatment for Persistent Methicillin‐ResistantStaphylococcus aureusBacteremia: Efficacy of Linezolid With or Without Carbapenem
  282. oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae
  283. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiellaspecies: A retrospective matched case-control study
  284. Diagnostic Usefulness of a T-cell-based Assay for Extrapulmonary Tuberculosis in Immunocompromised Patients
  285. Human bloodstream infection caused by Staphylococcus pettenkoferi
  286. Usefulness of the whole-blood interferon-gamma release assay for diagnosis of extrapulmonary tuberculosis
  287. A Case of Plasmodium vivax Malaria with Cerebral Complicatio
  288. Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period
  289. Chronic cutaneous disseminated Trichosporon asahii infection in a nonimmunocompromised patient
  290. Risk factor analysis of invasive liver abscess caused by the K1 serotype Klebsiella pneumoniae
  291. Diagnosis of Central Nervous System Tuberculosis by T-Cell-Based Assays on Peripheral Blood and Cerebrospinal Fluid Mononuclear Cells
  292. Retrobulbar Optic Neuritis and Meningoencephalitis Following Progressive Outer Retinal Necrosis due to CMV in a Patient with AIDS
  293. Detection of Mycobacterium tuberculosis complex Using Real-time Polymerase Chain Reaction
  294. A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea
  295. Survey of community-associated methicillin-resistant Staphylococcus aureus in Korea--authors' response
  296. Effect of tumor necrosis factor-α on intracellularStaphylococcus aureusin vascular endothelial cells
  297. Effect of Highly Active Antiretroviral Therapy on Incidence of Early Syphilis in HIV-Infected Patients
  298. The Effects of an Institutional Care Map on the Admission Rates and Medical Costs in Women with Acute Pyelonephritis
  299. Self-reported reasons among HIV-infected patients for missing clinic appointments
  300. Comparison of Motility, Acrosome, Viability and ATP of Boar Sperm with or without Cold Shock Resistance in Liquid Semen at 17째C and 4째C, and Frozen-thawed Semen
  301. A Case of Diabetic Foot Infection due to Mycobacterium mageritense
  302. Adult Immunization Schedule Recommended by the Korean Society of Infectious Diseases, 2007
  303. Prevalence of Primary Antiretroviral Resistance: Trends in Korea
  304. Diagnostic Usefulness of a T-cell–Based Assay for Extrapulmonary Tuberculosis
  305. Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia
  306. In vitro ability of Staphylococcus aureus isolates from bacteraemic patients with and without metastatic complications to invade vascular endothelial cells
  307. A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea
  308. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults
  309. Early Modification of Initial HAART Regimen Associated with Poor Clinical Outcome in HIV Patients
  310. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea
  311. Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART
  312. Using Problem-based Learning to Teach Antibiotics use during a Clerkship in Internal Medicine
  313. Amebic Liver Abscess in HIV-infected Patients, Republic of Korea
  314. Effect of salicylic acid on invasion of human vascular endothelial cells byStaphylococcus aureus
  315. One‐year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients
  316. Diagnosis and Clinical Features of Food Poisoning
  317. Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis
  318. Castleman Disease Presenting with Jaundice: A Case with the Multicentric Hyaline Vascular Variant
  319. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination
  320. Ulcerofungating Rectal Mass Caused by Cytomegalovirus Infection in a Patient with AIDS
  321. Immune reconstitution inflammatory syndrome in the first year after HAART: influence on long-term clinical outcome
  322. Cell-Mediated Immune Responses to Smallpox Vaccination
  323. Prediction of Residual Immunity to Smallpox, by Means of an Intradermal Skin Test with Inactivated Vaccinia Virus
  324. Treatment Failure Due to Emergence of Resistance to Carbapenem during Therapy for Shewanella algae Bacteremia
  325. Prevalence and Clinical Implications ofStaphylococcus aureuswith a Vancomycin MIC of 4µg/ml in Korea
  326. Spontaneous Cryptococcal Peritonitis in Patients with Liver Cirrhosis
  327. A Case of Hypersensitivity Syndrome to Both Vancomycin and Teicoplanin
  328. Community-Acquired versus Nosocomial Klebsiella pneumoniae Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance
  329. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores
  330. Clinical Responses to Smallpox Vaccine in Vaccinia‐Naive and Previously Vaccinated Populations: Undiluted and Diluted Lancy‐Vaxina Vaccine in a Single‐Blind, Randomized, Prospective Trial
  331. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia
  332. Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis
  333. Cytokine responses induced by Mycobacterium tuberculosis in patients with HIV-1 infection and tuberculosis
  334. Risk Factors for Antimicrobial Resistance and Influence of Resistance on Mortality in Patients with Bloodstream Infection Caused byPseudomonas aeruginosa
  335. Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome
  336. Pertussis in adults with persistent cough in South Korea
  337. Clinical Epidemiology of Ciprofloxacin Resistance and Its Relationship to Broad-Spectrum Cephalosporin Resistance in Bloodstream Infections Caused by Enterobacter Species
  338. Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy
  339. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type β-lactamase
  340. Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-β-Lactamase-Producing Klebsiella pneumoniae
  341. Risk Factors for and Clinical Outcomes of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
  342. Bloodstream Infections Caused by Enterobacter Species: Predictors of 30-Day Mortality Rate and Impact of Broad-Spectrum Cephalosporin Resistance on Outcome
  343. A High Frequency of Macrolide-Lincosamide-Streptogramin Resistance Determinants in<I> Staphylococcus aureus</I> Isolated in South Korea
  344. A High Frequency of Macrolide-Lincosamide-Streptogramin Resistance Determinants in Staphylococcus aureus Isolated in South Korea
  345. Transverse myelitis after measles and rubella vaccination
  346. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia
  347. Bilateral anterior uveitis as an unusual manifestation of Kikuchi-Fujimoto disease
  348. In Vitro Activities of 28 Antimicrobial Agents against Staphylococcus aureus Isolates from Tertiary-Care Hospitals in Korea: a Nationwide Survey
  349. Risk Factors for Ciprofloxacin Resistance in Bloodstream Infections Due to Extended-Spectrum β-Lactamase-ProducingEscherichia coliandKlebsiella pneumoniae
  350. Outcomes of Hickman Catheter Salvage in Febrile Neutropenic Cancer Patients WithStaphylococcus aureusBacteremia
  351. Genotypic Resistance of Antiretroviral Drugs among Drug-Naive HIV Type 1 Patients with the Background of Long-Term Access-Easy Zidovudine Therapy
  352. Outcome ofStaphylococcus aureusBacteremia in Patients with Eradicable Foci versus Noneradicable Foci
  353. Pseudomonas aeruginosaBacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome
  354. Nationwide Surveillance for Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Korea
  355. Determination of Genetic Subtypes of HIV Type 1 Isolated from Korean AIDS Patients
  356. Spectrum of Opportunistic Infections and Malignancies in Patients with Human Immunodeficiency Virus Infection in South Korea